Oncternal Therapeutics (NASDAQ:ONCT) Earns Hold Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a research note released on Friday. The firm issued a hold rating on the stock. Oncternal Therapeutics Price Performance Shares of NASDAQ ONCT opened at $0.53 on Friday. Oncternal Therapeutics has a twelve month low of $0.53 and a twelve month high […]
StockNews.com assumed coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a research note released on Friday. The firm issued a hold rating on the stock. Oncternal Therapeutics Price Performance Shares of NASDAQ ONCT opened at $0.53 on Friday. Oncternal Therapeutics has a twelve month low of $0.53 and a twelve month high […]
-logo-1200x675.gif&w=240&h=240&zc=2){kind=logo}
